公开(公告)号：US20240228542A1

公开(公告)日：2024-07-11

申请号：US17914303

申请日：2021-03-26

Applicant: A28 Therapeutics Inc.

Inventor： Carola Leuschner ,  Hector Alila ,  Anil Sood ,  Mark Kim

IPC: C07K7/23 ,  A61K31/704 ,  A61K38/00 ,  A61K47/64 ,  A61P35/00 ,  C07K7/08 ,  C07K14/59

CPC classification number: C07K7/23 ,  A61K31/704 ,  A61K47/64 ,  A61P35/00 ,  C07K7/08 ,  C07K14/59 ,  A61K38/00 ,  C07K2319/00

Abstract: The invention relates to fusion constructs and checkpoint inhibitors, methods of using fusion constructs and checkpoint inhibitors, and methods of treating undesirable or aberrant cell proliferation or hyperproliferative disorders, such as tumors, cancers, neoplasia and malignancies.